Tong CJ - Search Results

1

Long-term outcomes of pelvic exenterations for gynecological malignancies: a single-center retrospective cohort study.

Yu JH, Tong CJ, Huang QD, Ye YL, Chen G, Li H, Wen YS, Yang F, Luo NB, Xu GY, Xiong Y. Yu JH, et al. Among authors: tong cj. BMC Cancer. 2024 Jan 17;24(1):88. doi: 10.1186/s12885-024-11836-3. BMC Cancer. 2024. PMID: 38229045 Free PMC article.

2

Putative stem cell markers in cervical squamous cell carcinoma are correlated with poor clinical outcome.

Hou T, Zhang W, Tong C, Kazobinka G, Huang X, Huang Y, Zhang Y. Hou T, et al. BMC Cancer. 2015 Oct 24;15:785. doi: 10.1186/s12885-015-1826-4. BMC Cancer. 2015. PMID: 26499463 Free PMC article.

3

Minimally invasive surgery vs laparotomy for early stage cervical cancer: A propensity score-matched cohort study.

Dai D, Huang H, Feng Y, Wan T, Liu Z, Tong C, Liu J. Dai D, et al. Cancer Med. 2020 Dec;9(24):9236-9245. doi: 10.1002/cam4.3527. Epub 2020 Nov 25. Cancer Med. 2020. PMID: 33236825 Free PMC article.

4

Genomic profiling of advanced cervical cancer to predict response to programmed death-1 inhibitor combination therapy: a secondary analysis of the CLAP trial.

Huang X, He M, Peng H, Tong C, Liu Z, Zhang X, Shao Y, Zhu D, Zhang J, Yin JC, Yang F, Lan C. Huang X, et al. J Immunother Cancer. 2021 May;9(5):e002223. doi: 10.1136/jitc-2020-002223. J Immunother Cancer. 2021. PMID: 34011535 Free PMC article. Clinical Trial.

5

4EBP1-mediated SLC7A11 protein synthesis restrains ferroptosis triggered by MEK inhibitors in advanced ovarian cancer.

Yin J, Chen J, Hong JH, Huang Y, Xiao R, Liu S, Deng P, Sun Y, Chai KXY, Zeng X, Chan JY, Guan P, Wang Y, Wang P, Tong C, Yu Q, Xia X, Ong CK, Teh BT, Xiong Y, Tan J. Yin J, et al. JCI Insight. 2024 Jun 6;9(14):e177857. doi: 10.1172/jci.insight.177857. JCI Insight. 2024. PMID: 38842940 Free PMC article.

6

Comparison of PARPis with Angiogenesis Inhibitors and Chemotherapy for Maintenance in Ovarian Cancer: A Network Meta-Analysis.

Feng Y, Huang H, Wan T, Zhang C, Tong C, Liu J. Feng Y, et al. Adv Ther. 2019 Dec;36(12):3368-3380. doi: 10.1007/s12325-019-01106-1. Epub 2019 Oct 10. Adv Ther. 2019. PMID: 31599396

7

Overexpression of ASAP1 is associated with poor prognosis in epithelial ovarian cancer.

Hou T, Yang C, Tong C, Zhang H, Xiao J, Li J. Hou T, et al. Int J Clin Exp Pathol. 2013 Dec 15;7(1):280-7. eCollection 2014. Int J Clin Exp Pathol. 2013. PMID: 24427349 Free PMC article.

8

Role of Lymphadenectomy During Interval Debulking Surgery Performed After Neoadjuvant Chemotherapy in Patients With Advanced Ovarian Cancer.

He M, Lai Y, Peng H, Tong C. He M, et al. Front Oncol. 2021 Mar 26;11:646135. doi: 10.3389/fonc.2021.646135. eCollection 2021. Front Oncol. 2021. PMID: 33842358 Free PMC article.

9

Multiparametric immune profiling of advanced cervical cancer to predict response to programmed death-1 inhibitor combination therapy: an exploratory study of the CLAP trial.

Wang Y, Lai Y, Peng H, Yan S, Liu Z, Tong C, Huang X. Wang Y, et al. Clin Transl Oncol. 2023 Jan;25(1):256-268. doi: 10.1007/s12094-022-02945-1. Epub 2022 Sep 17. Clin Transl Oncol. 2023. PMID: 36115931

10

Expression of COL6A1 predicts prognosis in cervical cancer patients.

Hou T, Tong C, Kazobinka G, Zhang W, Huang X, Huang Y, Zhang Y. Hou T, et al. Am J Transl Res. 2016 Jun 15;8(6):2838-44. eCollection 2016. Am J Transl Res. 2016. PMID: 27398167 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

33 results

Search Page

Filters